The global Ropivacaine Injection market was valued at US$ 870 million in 2023 and is anticipated to reach US$ 1973.3 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.

Ropivacaine Injection Market

Ropivacaine injection is used to cause numbness or loss of feeling in patients before and during surgery or labor and delivery. It is also used to relieve acute pain. Ropivacaine is a local anesthetic and does not cause loss of consciousness.

Anesthetics are an indispensable class of important chemical substances in modern clinical surgery. The mechanism of action is to inhibit and block the conduction of nerve impulses. It plays an important role in alleviating the pain of patients and promoting the development of surgical medicine. With the development of medicine, more attention is paid to the patient's somatosensory, and the increase of painless surgery has promoted this market.

This report aims to provide a comprehensive presentation of the global market for Ropivacaine Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ropivacaine Injection.

Report Scope

The Ropivacaine Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ropivacaine Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ropivacaine Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Ropivacaine Injection Market Report

Report Metric	Details
Report Name	Ropivacaine Injection Market
Accounted market size in 2023	US$ 870 million
Forecasted market size in 2030	US$ 1973.3 million
CAGR	6.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	2 mg/mL (0.2%) 5 mg/mL (0.5%) 7.5 mg/mL (0.75%) 10 mg/mL (1%)
Segment by Application	Surgical Anesthesia Major Nerve Block Acute Pain Management Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Akorn, Anant Pharmaceuticals, SGPharma, Nephron Pharmaceuticals, Sintetica SA, AstraZeneca, Manus Aktteva Biopharma LLP, Zhejiang Xianju Pharmaceutical Co.,Ltd, Jiangsu Nhwa Pharmaceutical Co.,Ltd., Yangzi River Pharmaceutical Group, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Jiangsu Nhwa Pharmaceutical Co.,Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ropivacaine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ropivacaine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Ropivacaine Injection Market growing?

Ans: The Ropivacaine Injection Market witnessing a CAGR of 6.4% during the forecast period 2024-2030.

What is the Ropivacaine Injection Market size in 2030?

Ans: The Ropivacaine Injection Market size in 2030 will be US$ 1973.3 million.

Who are the main players in the Ropivacaine Injection Market report?

Ans: The main players in the Ropivacaine Injection Market are Pfizer, Akorn, Anant Pharmaceuticals, SGPharma, Nephron Pharmaceuticals, Sintetica SA, AstraZeneca, Manus Aktteva Biopharma LLP, Zhejiang Xianju Pharmaceutical Co.,Ltd, Jiangsu Nhwa Pharmaceutical Co.,Ltd., Yangzi River Pharmaceutical Group, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Jiangsu Nhwa Pharmaceutical Co.,Ltd

What are the Application segmentation covered in the Ropivacaine Injection Market report?

Ans: The Applications covered in the Ropivacaine Injection Market report are Surgical Anesthesia, Major Nerve Block, Acute Pain Management, Other

What are the Type segmentation covered in the Ropivacaine Injection Market report?

Ans: The Types covered in the Ropivacaine Injection Market report are 2 mg/mL (0.2%), 5 mg/mL (0.5%), 7.5 mg/mL (0.75%), 10 mg/mL (1%)

1 Ropivacaine Injection Market Overview

1.1 Product Overview and Scope of Ropivacaine Injection

1.2 Ropivacaine Injection Segment by Type

1.2.1 Global Ropivacaine Injection Market Value Comparison by Type (2024-2030)

1.2.2 2 mg/mL (0.2%)

1.2.3 5 mg/mL (0.5%)

1.2.4 7.5 mg/mL (0.75%)

1.2.5 10 mg/mL (1%)

1.3 Ropivacaine Injection Segment by Application

1.3.1 Global Ropivacaine Injection Market Value by Application: (2024-2030)

1.3.2 Surgical Anesthesia

1.3.3 Major Nerve Block

1.3.4 Acute Pain Management

1.3.5 Other

1.4 Global Ropivacaine Injection Market Size Estimates and Forecasts

1.4.1 Global Ropivacaine Injection Revenue 2019-2030

1.4.2 Global Ropivacaine Injection Sales 2019-2030

1.4.3 Global Ropivacaine Injection Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Ropivacaine Injection Market Competition by Manufacturers

2.1 Global Ropivacaine Injection Sales Market Share by Manufacturers (2019-2024)

2.2 Global Ropivacaine Injection Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Ropivacaine Injection Average Price by Manufacturers (2019-2024)

2.4 Global Ropivacaine Injection Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Ropivacaine Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Ropivacaine Injection, Product Type & Application

2.7 Ropivacaine Injection Market Competitive Situation and Trends

2.7.1 Ropivacaine Injection Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Ropivacaine Injection Players Market Share by Revenue

2.7.3 Global Ropivacaine Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ropivacaine Injection Retrospective Market Scenario by Region

3.1 Global Ropivacaine Injection Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Ropivacaine Injection Global Ropivacaine Injection Sales by Region: 2019-2030

3.2.1 Global Ropivacaine Injection Sales by Region: 2019-2024

3.2.2 Global Ropivacaine Injection Sales by Region: 2025-2030

3.3 Global Ropivacaine Injection Global Ropivacaine Injection Revenue by Region: 2019-2030

3.3.1 Global Ropivacaine Injection Revenue by Region: 2019-2024

3.3.2 Global Ropivacaine Injection Revenue by Region: 2025-2030

3.4 North America Ropivacaine Injection Market Facts & Figures by Country

3.4.1 North America Ropivacaine Injection Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Ropivacaine Injection Sales by Country (2019-2030)

3.4.3 North America Ropivacaine Injection Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Ropivacaine Injection Market Facts & Figures by Country

3.5.1 Europe Ropivacaine Injection Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Ropivacaine Injection Sales by Country (2019-2030)

3.5.3 Europe Ropivacaine Injection Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Ropivacaine Injection Market Facts & Figures by Country

3.6.1 Asia Pacific Ropivacaine Injection Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Ropivacaine Injection Sales by Country (2019-2030)

3.6.3 Asia Pacific Ropivacaine Injection Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Ropivacaine Injection Market Facts & Figures by Country

3.7.1 Latin America Ropivacaine Injection Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Ropivacaine Injection Sales by Country (2019-2030)

3.7.3 Latin America Ropivacaine Injection Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Ropivacaine Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Ropivacaine Injection Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Ropivacaine Injection Sales by Country (2019-2030)

3.8.3 Middle East and Africa Ropivacaine Injection Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Ropivacaine Injection Sales by Type (2019-2030)

4.1.1 Global Ropivacaine Injection Sales by Type (2019-2024)

4.1.2 Global Ropivacaine Injection Sales by Type (2025-2030)

4.1.3 Global Ropivacaine Injection Sales Market Share by Type (2019-2030)

4.2 Global Ropivacaine Injection Revenue by Type (2019-2030)

4.2.1 Global Ropivacaine Injection Revenue by Type (2019-2024)

4.2.2 Global Ropivacaine Injection Revenue by Type (2025-2030)

4.2.3 Global Ropivacaine Injection Revenue Market Share by Type (2019-2030)

4.3 Global Ropivacaine Injection Price by Type (2019-2030)

5 Segment by Application

5.1 Global Ropivacaine Injection Sales by Application (2019-2030)

5.1.1 Global Ropivacaine Injection Sales by Application (2019-2024)

5.1.2 Global Ropivacaine Injection Sales by Application (2025-2030)

5.1.3 Global Ropivacaine Injection Sales Market Share by Application (2019-2030)

5.2 Global Ropivacaine Injection Revenue by Application (2019-2030)

5.2.1 Global Ropivacaine Injection Revenue by Application (2019-2024)

5.2.2 Global Ropivacaine Injection Revenue by Application (2025-2030)

5.2.3 Global Ropivacaine Injection Revenue Market Share by Application (2019-2030)

5.3 Global Ropivacaine Injection Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Corporation Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Ropivacaine Injection Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Pfizer Ropivacaine Injection Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Akorn

6.2.1 Akorn Corporation Information

6.2.2 Akorn Description and Business Overview

6.2.3 Akorn Ropivacaine Injection Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Akorn Ropivacaine Injection Product Portfolio

6.2.5 Akorn Recent Developments/Updates

6.3 Anant Pharmaceuticals

6.3.1 Anant Pharmaceuticals Corporation Information

6.3.2 Anant Pharmaceuticals Description and Business Overview

6.3.3 Anant Pharmaceuticals Ropivacaine Injection Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Anant Pharmaceuticals Ropivacaine Injection Product Portfolio

6.3.5 Anant Pharmaceuticals Recent Developments/Updates

6.4 SGPharma

6.4.1 SGPharma Corporation Information

6.4.2 SGPharma Description and Business Overview

6.4.3 SGPharma Ropivacaine Injection Sales, Revenue and Gross Margin (2019-2024)

6.4.4 SGPharma Ropivacaine Injection Product Portfolio

6.4.5 SGPharma Recent Developments/Updates

6.5 Nephron Pharmaceuticals

6.5.1 Nephron Pharmaceuticals Corporation Information

6.5.2 Nephron Pharmaceuticals Description and Business Overview

6.5.3 Nephron Pharmaceuticals Ropivacaine Injection Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Nephron Pharmaceuticals Ropivacaine Injection Product Portfolio

6.5.5 Nephron Pharmaceuticals Recent Developments/Updates

6.6 Sintetica SA

6.6.1 Sintetica SA Corporation Information

6.6.2 Sintetica SA Description and Business Overview

6.6.3 Sintetica SA Ropivacaine Injection Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Sintetica SA Ropivacaine Injection Product Portfolio

6.6.5 Sintetica SA Recent Developments/Updates

6.7 AstraZeneca

6.6.1 AstraZeneca Corporation Information

6.6.2 AstraZeneca Description and Business Overview

6.6.3 AstraZeneca Ropivacaine Injection Sales, Revenue and Gross Margin (2019-2024)

6.4.4 AstraZeneca Ropivacaine Injection Product Portfolio

6.7.5 AstraZeneca Recent Developments/Updates

6.8 Manus Aktteva Biopharma LLP

6.8.1 Manus Aktteva Biopharma LLP Corporation Information

6.8.2 Manus Aktteva Biopharma LLP Description and Business Overview

6.8.3 Manus Aktteva Biopharma LLP Ropivacaine Injection Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Manus Aktteva Biopharma LLP Ropivacaine Injection Product Portfolio

6.8.5 Manus Aktteva Biopharma LLP Recent Developments/Updates

6.9 Zhejiang Xianju Pharmaceutical Co.,Ltd

6.9.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Corporation Information

6.9.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Description and Business Overview

6.9.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Product Portfolio

6.9.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates

6.10 Jiangsu Nhwa Pharmaceutical Co.,Ltd.

6.10.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Corporation Information

6.10.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Description and Business Overview

6.10.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Product Portfolio

6.10.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Developments/Updates

6.11 Yangzi River Pharmaceutical Group

6.11.1 Yangzi River Pharmaceutical Group Corporation Information

6.11.2 Yangzi River Pharmaceutical Group Ropivacaine Injection Description and Business Overview

6.11.3 Yangzi River Pharmaceutical Group Ropivacaine Injection Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Yangzi River Pharmaceutical Group Ropivacaine Injection Product Portfolio

6.11.5 Yangzi River Pharmaceutical Group Recent Developments/Updates

6.12 Jiangsu Hengrui Pharmaceuticals Co., Ltd.

6.12.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Corporation Information

6.12.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Description and Business Overview

6.12.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Product Portfolio

6.12.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates

6.13 Jiangsu Nhwa Pharmaceutical Co.,Ltd

6.13.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd Corporation Information

6.13.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Description and Business Overview

6.13.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Product Portfolio

6.13.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Ropivacaine Injection Industry Chain Analysis

7.2 Ropivacaine Injection Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Ropivacaine Injection Production Mode & Process

7.4 Ropivacaine Injection Sales and Marketing

7.4.1 Ropivacaine Injection Sales Channels

7.4.2 Ropivacaine Injection Distributors

7.5 Ropivacaine Injection Customers

8 Ropivacaine Injection Market Dynamics

8.1 Ropivacaine Injection Industry Trends

8.2 Ropivacaine Injection Market Drivers

8.3 Ropivacaine Injection Market Challenges

8.4 Ropivacaine Injection Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Akorn

Anant Pharmaceuticals

SGPharma

Nephron Pharmaceuticals

Sintetica SA

Astrazeneca plc

Manus Aktteva Biopharma LLP

Yangzi River Pharmaceutical Group

Jiangsu Hengrui Pharmaceuticals Co., Ltd

Pfizer Inc

Zhejiang Xianju Pharmaceutical Co., Ltd.

Jiangsu Nhwa Pharmaceutical Co. Ltd.

List of Tables

Table 1. Global Ropivacaine Injection Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Ropivacaine Injection Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Ropivacaine Injection Market Competitive Situation by Manufacturers in 2023

Table 4. Global Ropivacaine Injection Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Ropivacaine Injection Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Ropivacaine Injection Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Ropivacaine Injection Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Ropivacaine Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Ropivacaine Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Ropivacaine Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Ropivacaine Injection, Product Type & Application

Table 12. Global Key Manufacturers of Ropivacaine Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Ropivacaine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ropivacaine Injection as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Ropivacaine Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Ropivacaine Injection Sales by Region (2019-2024) & (K Units)

Table 18. Global Ropivacaine Injection Sales Market Share by Region (2019-2024)

Table 19. Global Ropivacaine Injection Sales by Region (2025-2030) & (K Units)

Table 20. Global Ropivacaine Injection Sales Market Share by Region (2025-2030)

Table 21. Global Ropivacaine Injection Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Ropivacaine Injection Revenue Market Share by Region (2019-2024)

Table 23. Global Ropivacaine Injection Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Ropivacaine Injection Revenue Market Share by Region (2025-2030)

Table 25. North America Ropivacaine Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Ropivacaine Injection Sales by Country (2019-2024) & (K Units)

Table 27. North America Ropivacaine Injection Sales by Country (2025-2030) & (K Units)

Table 28. North America Ropivacaine Injection Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Ropivacaine Injection Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Ropivacaine Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Ropivacaine Injection Sales by Country (2019-2024) & (K Units)

Table 32. Europe Ropivacaine Injection Sales by Country (2025-2030) & (K Units)

Table 33. Europe Ropivacaine Injection Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Ropivacaine Injection Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Ropivacaine Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Ropivacaine Injection Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Ropivacaine Injection Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Ropivacaine Injection Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Ropivacaine Injection Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Ropivacaine Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Ropivacaine Injection Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Ropivacaine Injection Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Ropivacaine Injection Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Ropivacaine Injection Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Ropivacaine Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Ropivacaine Injection Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Ropivacaine Injection Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Ropivacaine Injection Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Ropivacaine Injection Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Ropivacaine Injection Sales (K Units) by Type (2019-2024)

Table 51. Global Ropivacaine Injection Sales (K Units) by Type (2025-2030)

Table 52. Global Ropivacaine Injection Sales Market Share by Type (2019-2024)

Table 53. Global Ropivacaine Injection Sales Market Share by Type (2025-2030)

Table 54. Global Ropivacaine Injection Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Ropivacaine Injection Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Ropivacaine Injection Revenue Market Share by Type (2019-2024)

Table 57. Global Ropivacaine Injection Revenue Market Share by Type (2025-2030)

Table 58. Global Ropivacaine Injection Price (US$/Unit) by Type (2019-2024)

Table 59. Global Ropivacaine Injection Price (US$/Unit) by Type (2025-2030)

Table 60. Global Ropivacaine Injection Sales (K Units) by Application (2019-2024)

Table 61. Global Ropivacaine Injection Sales (K Units) by Application (2025-2030)

Table 62. Global Ropivacaine Injection Sales Market Share by Application (2019-2024)

Table 63. Global Ropivacaine Injection Sales Market Share by Application (2025-2030)

Table 64. Global Ropivacaine Injection Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Ropivacaine Injection Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Ropivacaine Injection Revenue Market Share by Application (2019-2024)

Table 67. Global Ropivacaine Injection Revenue Market Share by Application (2025-2030)

Table 68. Global Ropivacaine Injection Price (US$/Unit) by Application (2019-2024)

Table 69. Global Ropivacaine Injection Price (US$/Unit) by Application (2025-2030)

Table 70. Pfizer Corporation Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Ropivacaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Pfizer Ropivacaine Injection Product

Table 74. Pfizer Recent Developments/Updates

Table 75. Akorn Corporation Information

Table 76. Akorn Description and Business Overview

Table 77. Akorn Ropivacaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Akorn Ropivacaine Injection Product

Table 79. Akorn Recent Developments/Updates

Table 80. Anant Pharmaceuticals Corporation Information

Table 81. Anant Pharmaceuticals Description and Business Overview

Table 82. Anant Pharmaceuticals Ropivacaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Anant Pharmaceuticals Ropivacaine Injection Product

Table 84. Anant Pharmaceuticals Recent Developments/Updates

Table 85. SGPharma Corporation Information

Table 86. SGPharma Description and Business Overview

Table 87. SGPharma Ropivacaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. SGPharma Ropivacaine Injection Product

Table 89. SGPharma Recent Developments/Updates

Table 90. Nephron Pharmaceuticals Corporation Information

Table 91. Nephron Pharmaceuticals Description and Business Overview

Table 92. Nephron Pharmaceuticals Ropivacaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Nephron Pharmaceuticals Ropivacaine Injection Product

Table 94. Nephron Pharmaceuticals Recent Developments/Updates

Table 95. Sintetica SA Corporation Information

Table 96. Sintetica SA Description and Business Overview

Table 97. Sintetica SA Ropivacaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Sintetica SA Ropivacaine Injection Product

Table 99. Sintetica SA Recent Developments/Updates

Table 100. AstraZeneca Corporation Information

Table 101. AstraZeneca Description and Business Overview

Table 102. AstraZeneca Ropivacaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. AstraZeneca Ropivacaine Injection Product

Table 104. AstraZeneca Recent Developments/Updates

Table 105. Manus Aktteva Biopharma LLP Corporation Information

Table 106. Manus Aktteva Biopharma LLP Description and Business Overview

Table 107. Manus Aktteva Biopharma LLP Ropivacaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Manus Aktteva Biopharma LLP Ropivacaine Injection Product

Table 109. Manus Aktteva Biopharma LLP Recent Developments/Updates

Table 110. Zhejiang Xianju Pharmaceutical Co.,Ltd Corporation Information

Table 111. Zhejiang Xianju Pharmaceutical Co.,Ltd Description and Business Overview

Table 112. Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Product

Table 114. Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates

Table 115. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Corporation Information

Table 116. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Description and Business Overview

Table 117. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Product

Table 119. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Developments/Updates

Table 120. Yangzi River Pharmaceutical Group Corporation Information

Table 121. Yangzi River Pharmaceutical Group Description and Business Overview

Table 122. Yangzi River Pharmaceutical Group Ropivacaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Yangzi River Pharmaceutical Group Ropivacaine Injection Product

Table 124. Yangzi River Pharmaceutical Group Recent Developments/Updates

Table 125. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Corporation Information

Table 126. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Description and Business Overview

Table 127. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Product

Table 129. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates

Table 130. Jiangsu Nhwa Pharmaceutical Co.,Ltd Corporation Information

Table 131. Jiangsu Nhwa Pharmaceutical Co.,Ltd Description and Business Overview

Table 132. Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Product

Table 134. Jiangsu Nhwa Pharmaceutical Co.,Ltd Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Ropivacaine Injection Distributors List

Table 138. Ropivacaine Injection Customers List

Table 139. Ropivacaine Injection Market Trends

Table 140. Ropivacaine Injection Market Drivers

Table 141. Ropivacaine Injection Market Challenges

Table 142. Ropivacaine Injection Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Ropivacaine Injection

Figure 2. Global Ropivacaine Injection Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Ropivacaine Injection Market Share by Type in 2023 & 2030

Figure 4. 2 mg/mL (0.2%) Product Picture

Figure 5. 5 mg/mL (0.5%) Product Picture

Figure 6. 7.5 mg/mL (0.75%) Product Picture

Figure 7. 10 mg/mL (1%) Product Picture

Figure 8. Global Ropivacaine Injection Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Ropivacaine Injection Market Share by Application in 2023 & 2030

Figure 10. Surgical Anesthesia

Figure 11. Major Nerve Block

Figure 12. Acute Pain Management

Figure 13. Other

Figure 14. Global Ropivacaine Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Ropivacaine Injection Market Size (2019-2030) & (US$ Million)

Figure 16. Global Ropivacaine Injection Sales (2019-2030) & (K Units)

Figure 17. Global Ropivacaine Injection Average Price (US$/Unit) & (2019-2030)

Figure 18. Ropivacaine Injection Report Years Considered

Figure 19. Ropivacaine Injection Sales Share by Manufacturers in 2023

Figure 20. Global Ropivacaine Injection Revenue Share by Manufacturers in 2023

Figure 21. The Global 5 and 10 Largest Ropivacaine Injection Players: Market Share by Revenue in 2023

Figure 22. Ropivacaine Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 23. Global Ropivacaine Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Ropivacaine Injection Sales Market Share by Country (2019-2030)

Figure 25. North America Ropivacaine Injection Revenue Market Share by Country (2019-2030)

Figure 26. United States Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Ropivacaine Injection Sales Market Share by Country (2019-2030)

Figure 29. Europe Ropivacaine Injection Revenue Market Share by Country (2019-2030)

Figure 30. Germany Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Ropivacaine Injection Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Ropivacaine Injection Revenue Market Share by Region (2019-2030)

Figure 37. China Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. China Taiwan Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Ropivacaine Injection Sales Market Share by Country (2019-2030)

Figure 45. Latin America Ropivacaine Injection Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Ropivacaine Injection Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Ropivacaine Injection Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Ropivacaine Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Ropivacaine Injection by Type (2019-2030)

Figure 55. Global Revenue Market Share of Ropivacaine Injection by Type (2019-2030)

Figure 56. Global Ropivacaine Injection Price (US$/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Ropivacaine Injection by Application (2019-2030)

Figure 58. Global Revenue Market Share of Ropivacaine Injection by Application (2019-2030)

Figure 59. Global Ropivacaine Injection Price (US$/Unit) by Application (2019-2030)

Figure 60. Ropivacaine Injection Value Chain

Figure 61. Ropivacaine Injection Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions